A new study identifies oncostatin M (OSM) as a potential biomarker and therapeutic target for anti-tumor necrosis factor (TNF)-refractory inflammatory bowel disease (IBD), and pinpoints mucosal stromal cells as key players in OSM-mediated inflammation.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Predictive biomarkers for anti-TNF alpha therapy in IBD patients
Journal of Translational Medicine Open Access 16 March 2024
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Molodecky, N.A. et al. Gastroenterology 142, 46–54 (2012).
Guerra, I. & Bermejo, F. Clin. Exp. Gastroenterol. 7, 359–367 (2014).
Feagan, B.G. et al. N. Engl. J. Med. 369, 699–710 (2013).
Feagan, B.G. et al. N. Engl. J. Med. 375, 1946–1960 (2016).
Sands, B.E. et al. Inflamm. Bowel Dis. 23, 97–106 (2017).
West, N.R. et al. Nat. Med. 23, 579–589 (2017).
Hermanns, H. Cytokine Growth Factor Rev. 26, 545–558 (2015).
Sanchez, A. et al. J. Interferon Cytokine Res. 23, 193–201 (2003).
Beigel, F. et al. PLoS One 9, e93498 (2014).
Sandborn, W.J. et al. Gastroenterology 146, 85–95 (2014).
Kullberg, M.C. et al. J. Exp. Med. 203, 2485–2494 (2006).
Kullberg, M.C. et al. Infect. Immun. 69, 4232–4241 (2001).
Acknowledgements
The work was supported by grants from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (R01 DK044319, R01 DK051362, R01 DK053056 and R01 DK088199 to R.S.B.; and T32 DK007533 to W.M.K.).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Rights and permissions
About this article
Cite this article
Kim, W., Kaser, A. & Blumberg, R. A role for oncostatin M in inflammatory bowel disease. Nat Med 23, 535–536 (2017). https://doi.org/10.1038/nm.4338
Published:
Issue Date:
DOI: https://doi.org/10.1038/nm.4338
This article is cited by
-
Predictive biomarkers for anti-TNF alpha therapy in IBD patients
Journal of Translational Medicine (2024)